Publicaciones en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (15)

2021

  1. Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old

    European Journal of Pediatrics, Vol. 180, Núm. 7, pp. 2099-2106

2016

  1. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

2015

  1. Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5

  2. Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5

2014

  1. Genetic barrier to resistance for dolutegravir

    AIDS Reviews, Vol. 17, Núm. 1, pp. 59-68

  2. Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing

    Clinical Infectious Diseases, Vol. 59, Núm. 4, pp. 578-588

2012

  1. Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists

    AIDS Reviews, Vol. 14, Núm. 3, pp. 208-217

2011

  1. Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects

    PLoS ONE, Vol. 6, Núm. 5

2010

  1. Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains

    Chemistry and Biology, Vol. 17, Núm. 7, pp. 766-775

  2. Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure

    Antiviral Research, Vol. 88, Núm. 3, pp. 281-286

  3. Genotypic determination of HIV tropism - Clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists

    AIDS Reviews, Vol. 12, Núm. 3, pp. 135-148

2009

  1. HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations

    Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 2, pp. 251-258

  2. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression

    Antiviral Therapy, Vol. 14, Núm. 2, pp. 195-201

2007

  1. Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments

    Journal of Medical Virology, Vol. 79, Núm. 11, pp. 1617-1628

  2. The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells

    Blood, Vol. 109, Núm. 12, pp. 5337-5345